HUP0300896A2 - Beta-aminosav-nitril-származékok, eljárás az előállításukra, és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Beta-aminosav-nitril-származékok, eljárás az előállításukra, és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0300896A2 HUP0300896A2 HU0300896A HUP0300896A HUP0300896A2 HU P0300896 A2 HUP0300896 A2 HU P0300896A2 HU 0300896 A HU0300896 A HU 0300896A HU P0300896 A HUP0300896 A HU P0300896A HU P0300896 A2 HUP0300896 A2 HU P0300896A2
- Authority
- HU
- Hungary
- Prior art keywords
- lower alkyl
- aryl
- cycloalkyl
- hydrogen atom
- heteroaryl
- Prior art date
Links
- -1 Beta-amino acid nitrile Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000003118 aryl group Chemical group 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102000005927 Cysteine Proteases Human genes 0.000 abstract 1
- 108010005843 Cysteine Proteases Proteins 0.000 abstract 1
- 206010018364 Glomerulonephritis Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 abstract 1
- 208000032109 Transient ischaemic attack Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 208000007957 amaurosis fugax Diseases 0.000 abstract 1
- 238000002399 angioplasty Methods 0.000 abstract 1
- 208000007474 aortic aneurysm Diseases 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000010875 transient cerebral ischemia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
A találmány (I) általános képletű vegyületekre[mely képletben Rljelentése hidrogénatom, arilcsoport, -CO-Ra vagy -SO2-Rb, ahol Rajelentése kis szénatomszámú alkil-, kis szénatomszámú alkoxi-,cikloalkil-, cikloalkil-(kis szénatomszámú alkil)-, cikloalkil-(kisszénatomszámú alkoxi)-, cikloalkoxi-, aril-, ariloxi-, aril-(kisszénatomszámú alkil)-, aril-(kis szénatomszámú alkoxi)-, ariloxi-(kisszénatomszámnú alkil)-, aril-S-(kis szénatomszámú alkil)-, aril-(kisszénatomszámú alkenil)-, heteroaril-, heteroaril-(kis szénatomszámúalkil)- vagy heteroaril-(kis szénatomszámú alkoxi)-csoport; Rbjelentése aril-, aril-(kis szénatomszámú alkil)- vagy heteroaril-csoport; R2 jelentése hidrogénatom vagy kis szénatomszámúalkilcsoport; R3 jelentése hidrogénatom vagy kis szénatomszámúalkilcsoport; R4 jelentése hidrogénatom vagy kis szénatomszámúalkilcsoport; R5 jelentése hidrogénatom, kis szénatomszámú alkil-,cikloalkil- vagy arilcsoport; n értéke 1 vagy 2] és gyógyászatilagalkalmas sóikra és/vagy gyógyászatilag alkalmas észtereikrevonatkozik. A találmány szerinti vegyületek cisztein-proteázokkaltársult betegségek, pl. az alábbi betegségek kezelésére alkalmazhatók:osteoporosis, osteoarthritis, rheumatoid arthritis; tumormetasztázis,glomerulonephritis, atheroszklerozis, miokardiális infarktus, anginapectoris, labilis angina pectoris, stroke, plaquerepedés, átmenetiiskémás rohamok, amaurosis fugax, perifériás artériális elzáródásosbetegség, angioplasztika és stent áthelyezés utáni restenosis, hasiaortás aneurizmusképződés, gyulladás, autoimmun betegség, malária,szemfenékszövet citopátia és légzési betegség. A találmány kiterjed avegyületek előállítási eljárására és ezeket tartalmazógyógyszerkészítményekre is. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00112577 | 2000-06-14 | ||
PCT/EP2001/006541 WO2001096285A1 (en) | 2000-06-14 | 2001-06-08 | Beta-amino acid nitrile derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300896A2 true HUP0300896A2 (hu) | 2003-07-28 |
HUP0300896A3 HUP0300896A3 (en) | 2004-09-28 |
Family
ID=8168969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300896A HUP0300896A3 (en) | 2000-06-14 | 2001-06-08 | Beta-amino acid nitrile derivatives, process for their preparation and pharmaceutical compositions containing them |
Country Status (29)
Country | Link |
---|---|
US (1) | US6462076B2 (hu) |
EP (1) | EP1294679B1 (hu) |
JP (1) | JP3872427B2 (hu) |
KR (1) | KR20030029057A (hu) |
CN (1) | CN1324006C (hu) |
AR (1) | AR031594A1 (hu) |
AT (1) | ATE304997T1 (hu) |
AU (2) | AU2001266056B2 (hu) |
BR (1) | BR0111733A (hu) |
CA (1) | CA2410303C (hu) |
DE (1) | DE60113533T2 (hu) |
EC (1) | ECSP024383A (hu) |
ES (1) | ES2248346T3 (hu) |
HK (1) | HK1057539A1 (hu) |
HR (1) | HRP20020963A2 (hu) |
HU (1) | HUP0300896A3 (hu) |
IL (1) | IL153166A0 (hu) |
JO (1) | JO2234B1 (hu) |
MA (1) | MA26913A1 (hu) |
MX (1) | MXPA02012253A (hu) |
NO (1) | NO20025823D0 (hu) |
NZ (1) | NZ522587A (hu) |
PE (1) | PE20020064A1 (hu) |
PL (1) | PL359811A1 (hu) |
RU (1) | RU2245871C2 (hu) |
UY (1) | UY26769A1 (hu) |
WO (1) | WO2001096285A1 (hu) |
YU (1) | YU90802A (hu) |
ZA (1) | ZA200209415B (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9916575D0 (en) * | 1999-07-15 | 1999-09-15 | Cambridge Combinatorial Ltd | Solid phase nitrile synthesis |
EP1372655B1 (en) * | 2001-03-02 | 2008-10-01 | Merck Frosst Canada Ltd. | Cathepsin cysteine protease inhibitors |
EP1427696A1 (en) * | 2001-09-13 | 2004-06-16 | F. Hoffmann-La Roche Ag | Ccr-3 receptor antagonists v |
AU2002352126A1 (en) * | 2001-12-04 | 2003-06-17 | F. Hoffmann-La Roche Ag | Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
US6759428B2 (en) * | 2001-12-04 | 2004-07-06 | Roche Palo Alto Llc | Indole nitriles |
AU2003282983A1 (en) * | 2002-10-23 | 2004-05-13 | Bristol-Myers Squibb Company | Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
EP1633701A1 (en) * | 2003-06-02 | 2006-03-15 | F.Hoffmann-La Roche Ag | Benzamide nitrile derivatives |
WO2005000793A1 (ja) * | 2003-06-26 | 2005-01-06 | Taisho Pharmaceutical Co., Ltd. | 2位置換シクロアルキルカルボン酸誘導体 |
AU2004251794B2 (en) * | 2003-06-30 | 2010-08-19 | Merck Canada Inc. | Cathepsin cysteine protease inhibitors |
US20080125442A1 (en) * | 2005-01-19 | 2008-05-29 | Michael David Percival | Cathepsin K Inhibitors and Atherosclerosis |
CA2614070C (en) * | 2005-07-06 | 2014-03-25 | Merck Frosst Canada Ltd. | Cathepsin cysteine protease inhibitors |
JP5587790B2 (ja) | 2008-01-09 | 2014-09-10 | アミュラ セラピューティクス リミティド | 化合物 |
US7893099B2 (en) * | 2009-06-11 | 2011-02-22 | Hoffman-La Roche Inc. | Cyclopentane derivatives |
KR20140049019A (ko) | 2011-07-26 | 2014-04-24 | 사노피 | 3―헤테로아로일아미노―프로피온산 유도체 및 이의 약제로서의 용도 |
CN103086923B (zh) * | 2013-01-21 | 2014-04-23 | 吉林大学 | 肼腈类组织蛋白酶k抑制剂及其在治疗骨质疏松症方面的应用 |
CA2923272A1 (en) * | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
NO2699580T3 (hu) | 2014-01-24 | 2018-02-24 | ||
CN105837479B (zh) * | 2016-04-05 | 2017-10-27 | 吉林大学 | 肼腈类组织蛋白酶k抑制剂及其在制备治疗骨关节炎药物中的应用 |
CN113045491A (zh) * | 2019-12-26 | 2021-06-29 | 罗欣药业(上海)有限公司 | 一种仑伐替尼及中间体的制备方法 |
CN115996923A (zh) | 2020-08-26 | 2023-04-21 | 四川海思科制药有限公司 | 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途 |
JP2023551488A (ja) | 2020-12-04 | 2023-12-08 | 瑞石生物医薬有限公司 | カテプシンcの小分子阻害剤及びその医薬的使用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU177576B (en) | 1975-06-02 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 2-amino-cyclohexane carboxylic acid,its amides and similar compounds |
IT1283467B1 (it) | 1996-07-19 | 1998-04-21 | Menarini Farma Ind | Derivati di cicloalcani 1,2 sostituiti come inibitori della trombina, procedimento per la loro preparazione e loro impiego in formulazioni |
CN1282319A (zh) * | 1997-10-09 | 2001-01-31 | 小野药品工业株式会社 | 氨基丁酸衍生物 |
AU751669B2 (en) | 1997-11-05 | 2002-08-22 | Novartis Ag | Dipeptide nitriles |
-
2001
- 2001-06-01 US US09/872,927 patent/US6462076B2/en not_active Expired - Fee Related
- 2001-06-07 JO JO200188A patent/JO2234B1/en active
- 2001-06-08 IL IL15316601A patent/IL153166A0/xx unknown
- 2001-06-08 MX MXPA02012253A patent/MXPA02012253A/es active IP Right Grant
- 2001-06-08 YU YU90802A patent/YU90802A/sh unknown
- 2001-06-08 CN CNB018110819A patent/CN1324006C/zh not_active Expired - Fee Related
- 2001-06-08 RU RU2002135634/04A patent/RU2245871C2/ru not_active IP Right Cessation
- 2001-06-08 PE PE2001000541A patent/PE20020064A1/es not_active Application Discontinuation
- 2001-06-08 DE DE60113533T patent/DE60113533T2/de not_active Expired - Fee Related
- 2001-06-08 JP JP2002510429A patent/JP3872427B2/ja not_active Expired - Fee Related
- 2001-06-08 PL PL35981101A patent/PL359811A1/xx not_active Application Discontinuation
- 2001-06-08 KR KR1020027017073A patent/KR20030029057A/ko active IP Right Grant
- 2001-06-08 EP EP01943489A patent/EP1294679B1/en not_active Expired - Lifetime
- 2001-06-08 ES ES01943489T patent/ES2248346T3/es not_active Expired - Lifetime
- 2001-06-08 AU AU2001266056A patent/AU2001266056B2/en not_active Ceased
- 2001-06-08 BR BR0111733-5A patent/BR0111733A/pt not_active IP Right Cessation
- 2001-06-08 AT AT01943489T patent/ATE304997T1/de not_active IP Right Cessation
- 2001-06-08 AU AU6605601A patent/AU6605601A/xx active Pending
- 2001-06-08 NZ NZ522587A patent/NZ522587A/en unknown
- 2001-06-08 CA CA002410303A patent/CA2410303C/en not_active Expired - Fee Related
- 2001-06-08 HU HU0300896A patent/HUP0300896A3/hu unknown
- 2001-06-08 WO PCT/EP2001/006541 patent/WO2001096285A1/en active IP Right Grant
- 2001-06-12 AR ARP010102783A patent/AR031594A1/es not_active Application Discontinuation
- 2001-06-13 UY UY26769A patent/UY26769A1/es not_active Application Discontinuation
-
2002
- 2002-11-19 ZA ZA200209415A patent/ZA200209415B/en unknown
- 2002-12-04 NO NO20025823A patent/NO20025823D0/no not_active Application Discontinuation
- 2002-12-05 HR HR20020963A patent/HRP20020963A2/xx not_active Application Discontinuation
- 2002-12-13 MA MA26950A patent/MA26913A1/fr unknown
- 2002-12-13 EC EC2002004383A patent/ECSP024383A/es unknown
-
2004
- 2004-01-21 HK HK04100483A patent/HK1057539A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300896A2 (hu) | Beta-aminosav-nitril-származékok, eljárás az előállításukra, és ezeket tartalmazó gyógyszerkészítmények | |
MXPA04005263A (es) | 2-amino-cicloalcanocarboxamidas substituidas y su uso como inhibidores de cisteina proteasa. | |
SK1192002A3 (en) | Caspase inhibitors and uses thereof | |
CN104892525A (zh) | Lsd1的基于芳基环丙胺的脱甲基酶抑制剂及其医疗用途 | |
YU71102A (sh) | Supstituisani amidi benzoeve kiseline i njihova primena kao sredstva za lečenje | |
RU2007116037A (ru) | Новая кристаллическая форма (3-циано-1н-индол-7-ил)-[4-(4-фторфенэтил)пиперазин-1-ил]метанона, гидрохлорида | |
Tashima et al. | Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors | |
SI1490333T1 (sl) | Nove soli atorvastatina in farmacevtski sestavki, ki jih vsebujejo | |
Vaisburg et al. | (2-Amino-phenyl)-amides of ω-substituted alkanoic acids as new histone deacetylase inhibitors | |
BR0205683A (pt) | Processo para a preparação de derivados de piperazina, e, mesilato de um composto | |
Xie et al. | Anti-AIDS (acquired immune deficiency syndrome) agents. 17. New brominated hexahydroxybiphenyl derivatives as potent anti-HIV agents | |
HUP0102631A2 (hu) | 1,1- és 1,2-diszubtituált klórpropánszármazékok, eljárás előállításukra, és ilyen vegyületeket tartalmazó készítmények | |
CN1127506C (zh) | 一种治疗阳痿的新化合物 | |
JPH0761994B2 (ja) | ジセレノビス安息香酸アミド、その製造方法およびそれを含有する医薬製剤 | |
Zhang et al. | Synthesis and biological evaluation of N-(aminopyridine) benzamide analogues as histone deacetylase inhibitors | |
Ghanei-Nasab et al. | Synthesis and anti-acetylcholinesterase activity of N-[(indolyl) ethyl)-coumarin-yloxy)] alkanamides | |
HUP0203270A2 (hu) | Hidroxánsav-származék mint a humán CD23 termelés inhibitora, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE491686T1 (de) | Amlodipin-gentisat und verfahren zu dessen herstellung | |
ATE364036T1 (de) | Eintopfsynthese von 3-cyclopropylamino-2- 2,4- dibromo-3-(difluoromethoxy)benzoylö-2-propensäu e alkylester als nützliches zwischenprodukt für antibakterielle quinolon-arzneistoffe | |
HK1075656A1 (en) | New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds | |
JP2006500422A (ja) | 酵素活性を阻害するためのキレート化剤の親油性ジエステル | |
HUP0202293A2 (hu) | Új N-benzilpiperazin vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
CN108997230A (zh) | 具有基质金属蛋白酶抑制活性的喹喔啉衍生物及其制备方法和应用 | |
GB0116577D0 (en) | Succinic acid derivatives | |
Vélez Bernal et al. | Synthesis and Evaluation of Thiochroman-4-One Derivatives as Potential Leishmanicidal Agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |